An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Studying long-term data for Venetoclax in people who were previously taking the drug on other trials

Main Aims

This study is open to people who were given the drug Venetoclax on a previous trial, ensuring they can still access it until a point that the drug stops working for them. This helps researchers understand how the drug works long term in patients.

Recruitment Criteria

• You received Venetoclax in a previous study and continue to have a benefit from the drug

Recruitment status: Not Recruiting

Sponsor: Abbvie

Expected to end: 01/02/2026

Phases: Phase 3

Regions: East Midlands, London, North West England, South East England, South West England, West Midlands